The Indian Drug Manufacturers' Association (idma) has moved the Bombay High Court challenging various issues laid down in the amendments to the 1972 Patent Rules. The government had, in early June, notified the amendments to the Patent Rules following the enactment of the Patents (Amendment) Act, 1999. The petition, it is believed, challenges various "objectionable" clauses laid down in the rules. The drug body claims that the amended rules go much beyond the TRIPS requirements and even supercede the basic Patents (Amendment) Act, 1999.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
.png)
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.